SVA logo

Sinovac Biotech (SVA)

Profile

Full Name

Sinovac Biotech Ltd.

Ticker Symbol

SVA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

China

IPO

September 26, 2003

Indexes

Not included

Website

http://www.sinovacbio.com

Employees

1959

Key Details

Price

$6.47(0.00%)

Market cap

$464.94M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$448.27M(-69.97% YoY)

Annual EPS

-$1.06(-206.00% YoY)

PE ratio

-

Next earnings date

Aug 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.47
SVA price is $6.47

30-Day Relative Volume

-
SVA 30-day relative volume value is unknown

Price Performance

Price Most recent change

0%
SVA {parameterFullLabel} has remained unchanged on Apr 11, 2025

Price YTD change

0%
SVA {parameterFullLabel} has remained unchanged since January 1st

Price 1-year change

0%
SVA {parameterFullLabel} has remained unchanged year-on-year

Price 3-year change

0%
SVA {parameterFullLabel} has remained unchanged over the past 3 years

Price Range

Price All-time high

$12.50
SVA price is currently -48.24% below its historical high of $12.50

Price 3-year low

$6.47
SVA price is currently at its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$464.94M
SVA market capitalization is $464.94 million

Market cap 3-year change

-27.78%
SVA market capitalization is down -27.78% over the past 3 years

Market cap All-time high

$643.78M
SVA market capitalization is currently -27.78% below its historical high of $643.78 million

Market cap sector rank

68.61%
SVA market capitalization is higher than 68.61% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
SVA {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

-27.78%
SVA shares outstanding is down -27.78% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.00
SVA beta is 0.00

200-day SMA

$6.47
SVA price is currently equal to its 200-day simple moving average

50-day SMA

$6.47
SVA price is currently equal to its 50-day simple moving average

RSI

50.00
SVA 14-day relative strength index is 50.00

Volume

-
SVA 30-day relative volume value is unknown

ATR

$0.00
SVA average true range is $0.00

10-day Historical Volatility

0.00%
SVA 10-day historical volatility is 0.00%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$448.27M
SVA annual revenue is $448.27 million

Revenue Analysts estimate

-
SVA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-69.97%
SVA annual revenue is down -69.97% year-on-year

Revenue Sector rank

73.24%
SVA annual revenue is higher than 73.24% of companies in Healthcare sector

EPS

EPS

-$1.06
SVA annual earnings per share is -$1.06

EPS Analysts estimate

-$0.11
SVA annual earnings per share is currently +863.64% higher than the consensus analysts' forecast

EPS 1-year change

-206%
SVA annual earnings per share is down -206% year-on-year

EPS Sector rank

55.24%
SVA annual earnings per share is higher than 55.24% of companies in Healthcare sector

Profit

Gross profit

$266.75M
SVA annual gross profit is $266.75 million

Gross margin

59.51%
SVA annual gross profit margin is 59.51%

Operating profit

-$524.30M
SVA annual operating income is -$524.30 million

Operating margin

-116.96%
SVA annual operating profit margin is -116.96%

Net income

-$99.92M
SVA annual net profit is -$99.92 million

Net margin

-22.29%
SVA annual net profit margin is -22.29%

Expenses

Total expenses

$972.57M
SVA annual total expenses is $972.57 million

Operating expenses

$791.05M
SVA annual total operating expenses is $791.05 million

Cost of goods sold

$181.52M
SVA annual cost of goods sold is $181.52 million

Selling, general & administrative expenses

$466.32M
SVA annual SGA is $466.32 million

Depreciation and amortization

$144.75M
SVA annual depreciation & amortization is $144.75 million

Interest expense

$2.26M
SVA annual interest expense is $2.26 million

Income tax

$105.32M
SVA annual income tax is $105.32 million

EBIT & EBITDA

EBIT

-$150.77M
SVA annual earnings before interest & taxes is -$150.77 million

EBITDA

-$6.03M
SVA annual EBITDA is -$6.03 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$13.66B
SVA annual total assets is $13.66 billion

Non current assets

$1.83B
SVA annual long term assets is $1.83 billion

Current assets

$11.83B
SVA annual total current assets is $11.83 billion

Cash and cash equivalents

$1.27B
SVA annual cash & cash equivalents is $1.27 billion

Accounts receivable

$426.01M
SVA annual accounts receivable is $426.01 million

Inventory

$139.87M
SVA annual inventory is $139.87 million

Liabilities

Total liabilities

$1.64B
SVA annual total liabilities is $1.64 billion

Long term liabilities

$487.30M
SVA annual total long term liabilities is $487.30 million

Current liabilities

$1.15B
SVA annual total current liabilities is $1.15 billion

Accounts payable

$17.29M
SVA annual accounts payable is $17.29 million

Debt

Total debt

$298.98M
SVA annual total debt is $298.98 million

Total debt 1-year change

+300.39%
SVA annual total debt is up +300.39% year-on-year

Long term debt

$217.09M
SVA annual long term debt is $217.09 million

Short term debt

$81.89M
SVA annual short term debt is $81.89 million

Equity & Capital

Shareholders equity

$8.71B
SVA annual stockholders equity is $8.71 billion

Book value

$8.71B
SVA annual book value is $8.71 billion

Retained earnings

$7.12B
SVA annual retained earnings is $7.12 billion

Working capital

$10.68B
SVA annual working capital is $10.68 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$104.00M
SVA annual cash flow from operations is $104.00 million

Cash from operations 1-year change

+113.49%
SVA annual cash flow from operations is up +113.49% year-on-year

Cash from investing

-$2.92B
SVA annual cash flow from investing activities is -$2.92 billion

Cash from investing 1-year change

+49.24%
SVA annual cash flow from investing activities is up +49.24% year-on-year

Cash from financing

-$76.06M
SVA annual cash flow from financing activities is -$76.06 million

Cash from financing 1-year change

+68.49%
SVA annual cash flow from financing activities is up +68.49% year-on-year

CAPEX

CAPEX

$145.69M
SVA annual capital expenditures is $145.69 million

CAPEX 1-year change

-63.88%
SVA annual capital expenditures is down -63.88% year-on-year

Free Cash Flow

Free cash flow

-$41.69M
SVA annual free cash flow is -$41.69 million

Free cash flow 1-year change

+96.45%
SVA annual free cash flow is up +96.45% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

59.51%
SVA annual gross profit margin is 59.51%

Operating margin

-116.96%
SVA annual operating profit margin is -116.96%

Net margin

-22.29%
SVA annual net profit margin is -22.29%

ROA & ROE

ROA

-0.72%
SVA annual return on assets is -0.72%

ROE

-0.81%
SVA annual return on equity is -0.81%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SVA price to earnings ratio value is unknown

PE ratio Sector rank

-
SVA price to earnings ratio is unknown

PB Ratio

PB ratio

0.05
SVA price to book ratio is 0.05

PB ratio Sector rank

17.19%
SVA price to book ratio is higher than 17.19% of companies in Healthcare sector

PS Ratio

PS ratio

-
SVA price to sales ratio value is unknown

PS ratio Sector rank

-
SVA price to sales ratio is unknown

Enterprise value

Enterprise value

-$282.90M
SVA enterprise value is -$282.90 million

Enterprise value Sector rank

0.08%
SVA enterprise value is higher than 0.08% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
SVA EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
SVA EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

10.31
SVA annual current ratio is 10.31

Quick ratio

10.18
SVA annual quick ratio is 10.18

Leverage

Debt to equity

0.03
SVA annual debt to equity ratio is 0.03

Interest coverage ratio

-66.71
SVA annual interest coverage ratio is -66.71

Risk & Stability

Piotroski F-Score

-
SVA piotroski f-score value is unknown

Altman Z-Score

1.84
SVA altman z-score is 1.84

Analyst ratings

Recent major analysts updates

Mar 20, 14 Morgan Stanley
Overweight
Nov 13, 13 Aegis Capital
Buy
Aug 15, 13 Aegis Capital
Buy
May 15, 13 Morgan Stanley
Equal-Weight
Mar 14, 13 Aegis Capital
Hold
Dec 12, 12 Aegis Capital
Hold

Institutional Ownership

Similar stocks

KURA logo
Kura Oncology (KURA)
BCYC logo
Bicycle Therapeutics (BCYC)
URGN logo
UroGen Pharma (URGN)
Fortrea Holdings (FTRE)
TALK logo
Talkspace (TALK)
Niagen Bioscience (NAGE)
CDXC logo
ChromaDex (CDXC)
CCRN logo
Cross Country Healthcare (CCRN)
DNA logo
Ginkgo Bioworks Holdings (DNA)
  • What is the ticker symbol for Sinovac Biotech?
  • Does Sinovac Biotech pay dividends?
  • What sector is Sinovac Biotech in?
  • What industry is Sinovac Biotech in?
  • What country is Sinovac Biotech based in?
  • When did Sinovac Biotech go public?
  • Is Sinovac Biotech in the S&P 500?
  • Is Sinovac Biotech in the NASDAQ 100?
  • Is Sinovac Biotech in the Dow Jones?
  • When was Sinovac Biotech's last earnings report?
  • When does Sinovac Biotech report earnings?
  • Should I buy Sinovac Biotech stock now?

What is the ticker symbol for Sinovac Biotech?

The ticker symbol for Sinovac Biotech is NASDAQ:SVA

Does Sinovac Biotech pay dividends?

No, Sinovac Biotech does not pay dividends

What sector is Sinovac Biotech in?

Sinovac Biotech is in the Healthcare sector

What industry is Sinovac Biotech in?

Sinovac Biotech is in the Biotechnology industry

What country is Sinovac Biotech based in?

Sinovac Biotech is headquartered in China

When did Sinovac Biotech go public?

Sinovac Biotech's initial public offering (IPO) was on September 26, 2003

Is Sinovac Biotech in the S&P 500?

No, Sinovac Biotech is not included in the S&P 500 index

Is Sinovac Biotech in the NASDAQ 100?

No, Sinovac Biotech is not included in the NASDAQ 100 index

Is Sinovac Biotech in the Dow Jones?

No, Sinovac Biotech is not included in the Dow Jones index

When was Sinovac Biotech's last earnings report?

Sinovac Biotech's most recent earnings report was on Aug 16, 2024

When does Sinovac Biotech report earnings?

The next expected earnings date for Sinovac Biotech is Aug 15, 2025

Should I buy Sinovac Biotech stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page